TQB3107
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 30, 2026
TQB3107-I-01: A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
(clinicaltrials.gov)
- P1 | N=140 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Trial completion date: Dec 2026 ➔ Jun 2027 | Trial primary completion date: Jun 2025 ➔ Oct 2026
Trial completion date • Trial primary completion date • Oncology • Solid Tumor
July 03, 2024
TQB3107-I-01: A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
(clinicaltrials.gov)
- P1 | N=140 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
May 14, 2024
A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
(clinicaltrials.gov)
- P1 | N=140 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1